Skip to main content

Table 1 Baseline characteristic of patients with total hip arthroplasty

From: HIV infection is not associated with perioperative blood loss in patients undergoing total hip arthroplasty

Factors

HIV−

HIV+

P value

Gender, n (%)

  

0.001

 Men

16 (44.4)

19 (90.5)

 

 Women

20 (55.6)

2 (9.5)

 

Hypertension, n (%)

  

0.832

 Yes

13 (36.1)

7 (33.3)

 

 No

23 (63.9)

14 (66.7)

 

Diabetes, n (%)

  

0.070

 Yes

6 (16.7)

8 (38.1)

 

 No

30 (83.3)

13 (61.9)

 

BMI group

  

0.484

 Low-weight

5 (13.9)

4 (19.0)

 

 Normal

23 (63.9)

10 (47.6)

 

 Over-weight

8 (22.2)

7 (33.3)

 

Age, mean ± SD, years

60.97 ± 17.37

43.19 ± 12.06

< 0.001

Hb, mean ± SD, g/L

125.25 ± 22.87

137.67 ± 16.9

0.023

HCT, mean ± SD, g/L

38.92 ± 10.37

40.19 ± 4.82

0.600

ALB, mean ± SD, g/L

39.46 ± 3.96

42.63 ± 3.54

0.004

ESR, median (IQR), mm/h

40.0 (52)

18.5 (20.5)

0.088

hs-CRP, median (IQR), mg/L

5.6 (27.0)

4.7 (7.3)

0.330

BMI, mean ± SD, kg/m2

22.66 ± 4.93

22.35 ± 3.81

0.687

Drainage volume, Median (IQR), ml

140 (180)

100 (0)

0.029

Blood transfusion volume, Median (IQR), ml

580 (290)

580 (0)

0.451

Nutrition status, Median (IQR)

1 (2)

1 (0)

0.733

PT, mean ± SD, s

13.13 ± 1.13

12.81 ± 0.69

0.495

INR, mean ± SD

0.99 ± 0.11

0.96 ± 0.07

0.305

Fibrinogen, mean ± SD, g/L

3.81 ± 1.11

4.00 ± 1.05

0.540

Platelet count, mean ± SD, 109/L

244.13 ± 84.68

258.52 ± 58.69

0.717

  1. Hb: hemoglobin; HCT: hematocrit; ALB: albumin; ESR: erythrocyte sedimentation rate; hs-CRP: high sensitivity C-reactive protein; BMI: body mass index; PT: prothrombin time; INR: International normalized ratio